AKT Inhibitor TQB3912

**Semantic type:** Pharmacologic Substance

**Definition:** An orally bioavailable small molecule inhibitor of the serine/threonine protein kinase AKT (protein kinase B; v-akt murine thymoma viral oncogene homolog 1), with potential antineoplastic activity. Upon oral administration, AKT inhibitor TQB3912 targets, binds to and inhibits the activity of AKT, which may result in the inhibition of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. This may inhibit proliferation and induce apoptosis of tumor cells in which AKT is overexpressed. Activation of the PI3K/AKT signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents.

**Synonyms:** - Protein Kinase Inhibitor TQB3912 - TQB 3912 - TQB-3912 - TQB3912